No credit card. No commitment.
5000+ G2 reviews
Kadimastem Ltd.
Research
Public company
Founded in 2009
Ness Ziona, Center DistrictKadimastem Ltd.
ResearchPublic companyFounded in 2009Ness Ziona, Center District
EmployeesKadimastem Ltd.'s financial review
Kadimastem Ltd.'s Revenue (Yearly)
2.8M
Employees
39
Total Funding
23.3M
Last Funding Round
3.1M
other
KDST
Kadimastem Ltd. information
Kadimastem (TASE:KDST) A clinical stage biotech company introducing a cutting-edge TECHNOLOGY PLATFORM for the Development, Manufacturing, and Bio-Banking of functional human cells, providing OFF-THE-SHELF TREATMENT for multiple indications featuring ALS and Type 1 Diabetes as our top two leading projects.
Kadimastem Ltd. industries
Stem cells
Drug screening for myelin sheath
Human oligodendrocytes
Human beta cells
Kadimastem Ltd.'s financial review
Kadimastem Ltd.'s Revenue (Yearly)
2.8M
Employees
39
Total Funding
23.3M
Last Funding Round
3.1M
other
KDST
Employee Metrics
Technologies
Notable Alumni
Employees
Senior Quality Assurance Lead
Head of Diabetes research
External Director
Researcher PHD Student
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
